Breaking News Instant updates and real-time market news.

MRK

Merck

$69.24

0.88 (1.29%)

12:50
10/12/18
10/12
12:50
10/12/18
12:50

Merck calls lead puts 10:1

Merck calls lead puts 10:1. The stock up 78c to $69.15 and 10.6K Jan 70 - 72.5 call spreads bought for $1.12. While the spread is possibly a bullish earnings play - the company is due to report 10/25 - trade history shows a matching block of Jan 70 calls opened at $2.78 on 8/20. The call write rolled from Jan 65s with shares at $69.61 at that time. It's likely that the short calls are now being rolled to the higher 72.5 strike to adjust an overwrite and monetize the profit on the short 70 calls (which were bought back for $2.64 today). The adjustment expresses the view that shares will see limited upside through early-2019. Nov 70, Nov 75, and Oct 70 calls are next most active in Merck Friday. Total volume is 35K calls and 3.5K puts.

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 11

    Jan

  • 16

    Feb

MRK Merck
$69.24

0.88 (1.29%)

10/11/18
FBCO
10/11/18
NO CHANGE
Target $81
FBCO
Outperform
Merck price target raised to $81 from $71 at Credit Suisse
Credit Suisse analyst Vamil Divan raised his price target for Merck to $81 from $71, while reiterating an Outperform rating on the shares. While the shares have had a significant move this year, the analyst sees room for additional upside as the company continues to roll out Keytruda, most notably in the 1st line non-small cell lung setting. However, Divan also acknowledges longer-term investors remain concerned about how the company will navigate the Januvia patent expiration in mid-2022.
10/08/18
GUGG
10/08/18
INITIATION
Target $84
GUGG
Buy
Merck initiated with a Buy at Guggenheim
Guggenheim analyst Seamus Fernandez started Merck with a Buy rating and $84 price target, citing the sales and EPS upside he sees as Keytruda growth expands in the U.S. and globally. He also sees some partner products, such as Lynparza and Lenvima, along with the company's pipeline as being underappreciated, Fernandez tells investors.
10/03/18
HCWC
10/03/18
NO CHANGE
Target $4
HCWC
Buy
H.C. Wainwright positive on BioLineRx economic stake increase in BL-8040
H.C. Wainwright analyst Joseph Pantginis notes that BioLineRx (BLRX) announced the increase of its economic stake in BL-8040 from 60% to 80% from Biokine Therapeutics. The analyst believes that this transaction should signal increased confidence to investors as to the company's increased investment into BL-8040. Additionally, Pantginis argues that COMBAT data at ESMO later this month represents a potential tipping point for shares. COMBAT is a Phase 2a open-label study evaluating the safety and efficacy of BL-8040 in combination with pembrolizumab in patients with advanced pancreatic cancer in collaboration with Merck (MRK). He reiterates a Buy rating and $4 price target on BioLineRx shares.
08/23/18
MSCO
08/23/18
NO CHANGE
Target $74
MSCO
Overweight
Merck price target raised to $74 from $68 at Morgan Stanley
Morgan Stanley analyst David Risinger maintained an Overweight rating on Merck and raised his price target to $74 from $68, citing his expectation for operating leverage to become more visible in 2019 and pipeline progress to improve perception about prospects in the face of Januvia generics in January 2023. Looking ahead, Risinger projects Merck's 5-year CAGR from 2018-2023 for revenue growth of 3% and EPS growth of 8%. Risinger says he believes the primary driver of major pharma stock performance in recent months is "defensive rotation." Looking ahead, the analyst says to watch for U.S. pricing perception drivers in the coming months that could impact pharma stock performance, including potential additional HHS action on drug rebates, November election results and manufacturer communication and action on U.S. list prices by early January.

TODAY'S FREE FLY STORIES

NDLS

Noodles & Company

$12.70

0.11 (0.87%)

20:12
10/23/18
10/23
20:12
10/23/18
20:12
Conference/Events
Noodles & Company participates in a conference call with Jefferies »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

LIQT

LiqTech

$1.31

-0.01 (-0.76%)

20:02
10/23/18
10/23
20:02
10/23/18
20:02
Conference/Events
LiqTech to host conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

19:45
10/23/18
10/23
19:45
10/23/18
19:45
General news
Breaking General news story  »

Kansas City Federal…

FBMS

First Bancshares

$35.68

-0.53 (-1.46%)

19:36
10/23/18
10/23
19:36
10/23/18
19:36
Earnings
First Bancshares reports Q3 adjusted EPS 62c, consensus 60c »

Reports Q3 NII $21.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTI

Proteostasis

$7.39

0.22 (3.07%)

19:30
10/23/18
10/23
19:30
10/23/18
19:30
Syndicate
Proteostasis 11M share Secondary priced at $6.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NCOM

National Commerce

$37.80

0.38 (1.02%)

19:19
10/23/18
10/23
19:19
10/23/18
19:19
Earnings
National Commerce reports Q3 EPS 59c, consensus 63c »

"We are pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Dec

ON

ON Semiconductor

$16.09

0.21 (1.32%)

19:14
10/23/18
10/23
19:14
10/23/18
19:14
Hot Stocks
ON Semiconductor announces CE certification for Sigfox RF solution »

ON Semiconductor has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 08

    May

LPT

Liberty Property

$41.51

1.285 (3.19%)

, CMCSA

Comcast

$35.63

-0.12 (-0.34%)

19:10
10/23/18
10/23
19:10
10/23/18
19:10
Recommendations
Liberty Property, Comcast analyst commentary  »

Liberty Property price…

LPT

Liberty Property

$41.51

1.285 (3.19%)

CMCSA

Comcast

$35.63

-0.12 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 25

    Oct

  • 07

    Nov

MANH

Manhattan Associates

$47.61

-0.36 (-0.75%)

, RRC

Range Resources

$16.46

-0.24 (-1.44%)

18:55
10/23/18
10/23
18:55
10/23/18
18:55
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

MANH

Manhattan Associates

$47.61

-0.36 (-0.75%)

RRC

Range Resources

$16.46

-0.24 (-1.44%)

TER

Teradyne

$32.20

-0.09 (-0.28%)

TSS

TSYS

$92.62

-0.85 (-0.91%)

NAVI

Navient

$12.40

-0.13 (-1.04%)

COF

Capital One

$87.12

-1.5 (-1.69%)

JNPR

Juniper

$27.37

-1.11 (-3.90%)

RHI

Robert Half

$64.01

0.63 (0.99%)

CMTA

Clementia Pharmaceuticals

$10.00

0.41 (4.28%)

APC

Anadarko

$61.84

-2.1 (-3.28%)

COG

Cabot Oil & Gas

$22.72

-0.44 (-1.90%)

AKRX

Akorn

$6.47

-0.12 (-1.82%)

IIVI

II-VI

$38.01

-0.44 (-1.14%)

NDLS

Noodles & Company

$12.70

0.11 (0.87%)

MKSI

MKS Instruments

$73.35

-1.13 (-1.52%)

IRBT

iRobot

$91.69

0.91 (1.00%)

CSL

Carlisle

$102.37

-0.64 (-0.62%)

TXN

Texas Instruments

$100.25

0.51 (0.51%)

EW

Edwards Lifesciences

$148.31

-1.175 (-0.79%)

AI

Arlington Asset Investment

$8.34

-0.07 (-0.83%)

UMBF

UMB Financial

$62.37

-1.32 (-2.07%)

FCF

First Commonwealth

$14.66

0.245 (1.70%)

VAR

Varian Medical

$104.27

-0.24 (-0.23%)

QEP

QEP Resources

$9.74

-0.52 (-5.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 09

    Nov

  • 25

    Oct

BLK

BlackRock

$387.58

-4.76 (-1.21%)

, ISNPY

Intesa Sanpaolo

$0.00

(0.00%)

18:51
10/23/18
10/23
18:51
10/23/18
18:51
Periodicals
BlackRock cools on buying Intesa asset management unit stake, Bloomberg says »

BlackRock's (BLK)…

BLK

BlackRock

$387.58

-4.76 (-1.21%)

ISNPY

Intesa Sanpaolo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

PAAS

Pan American Silver

$15.09

-0.19 (-1.24%)

18:50
10/23/18
10/23
18:50
10/23/18
18:50
Hot Stocks
Pan American Silver announces major discovery at La Colorada in Mexico »

Pan American Silver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

PFE

Pfizer

$44.09

-0.28 (-0.63%)

, LLY

Eli Lilly

$110.41

-1.66 (-1.48%)

18:42
10/23/18
10/23
18:42
10/23/18
18:42
Hot Stocks
Pfizer, Eli Lilly: Phase 3 study of tanezumab met all three co-primary endpoints »

Pfizer (PFE) and Eli…

PFE

Pfizer

$44.09

-0.28 (-0.63%)

LLY

Eli Lilly

$110.41

-1.66 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

EXPI

eXp World Holdings

$12.11

-0.39 (-3.12%)

18:31
10/23/18
10/23
18:31
10/23/18
18:31
Hot Stocks
eXp World Holdings signs LOI to acquire VirBELA, terms not disclosed »

eXp World Holdings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

IIVI

II-VI

$38.01

-0.44 (-1.14%)

18:26
10/23/18
10/23
18:26
10/23/18
18:26
Initiation
II-VI initiated  »

II-VI initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

XOM

Exxon Mobil

$79.83

-1.32 (-1.63%)

, CVX

Chevron

$113.41

-3.82 (-3.26%)

18:22
10/23/18
10/23
18:22
10/23/18
18:22
Periodicals
Endeavor Energy explores possible sale of company, WSJ reports »

Endeavor Energy Resources…

XOM

Exxon Mobil

$79.83

-1.32 (-1.63%)

CVX

Chevron

$113.41

-3.82 (-3.26%)

BP

BP

$42.30

-0.855 (-1.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

VMI

Valmont

$127.55

-1.68 (-1.30%)

18:09
10/23/18
10/23
18:09
10/23/18
18:09
Hot Stocks
Breaking Hot Stocks news story on Valmont »

Valmont lowers FY18 free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

VMI

Valmont

$127.55

-1.68 (-1.30%)

18:08
10/23/18
10/23
18:08
10/23/18
18:08
Earnings
Valmont lowers FY18 EPS view to $7.50-$7.65 from $7.55-$7.65, consensus $7.58 »

Sees FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

VMI

Valmont

$127.55

-1.68 (-1.30%)

18:06
10/23/18
10/23
18:06
10/23/18
18:06
Earnings
Valmont reports Q3 adjusted EPS $1.82, consensus $1.71 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NWE

NorthWestern

$59.47

-0.79 (-1.31%)

18:04
10/23/18
10/23
18:04
10/23/18
18:04
Earnings
NorthWestern reports Q3 adjusted EPS 58c, consensus 72c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQS

Equus II Inc

$1.95

(0.00%)

18:04
10/23/18
10/23
18:04
10/23/18
18:04
Hot Stocks
Equus Energy sells portion of interest in Haley Field for $600,000 »

Equus Total Return…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWE

NorthWestern

$59.47

-0.79 (-1.31%)

18:02
10/23/18
10/23
18:02
10/23/18
18:02
Earnings
Breaking Earnings news story on NorthWestern »

NorthWestern backs FY18…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWE

NorthWestern

$59.47

-0.79 (-1.31%)

18:01
10/23/18
10/23
18:01
10/23/18
18:01
Earnings
NorthWestern reports Q3 EPS 56c, consensus 72c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCMGY

Newcrest Mining

$0.00

(0.00%)

18:00
10/23/18
10/23
18:00
10/23/18
18:00
Hot Stocks
Newcrest Mining reports Q1 gold production 548K oz, up 5% from last year »

Reports Q1 copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

18:00
10/23/18
10/23
18:00
10/23/18
18:00
General news
Breaking General news story  »

Chicago Federal Reserve…

FSLR

First Solar

$44.21

-1.13 (-2.49%)

, FB

Facebook

$154.40

-0.41 (-0.26%)

17:59
10/23/18
10/23
17:59
10/23/18
17:59
Hot Stocks
First Solar to support PacifiCorp in meeting Facebook clean energy goals »

A solar power plant…

FSLR

First Solar

$44.21

-1.13 (-2.49%)

FB

Facebook

$154.40

-0.41 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.